As partner to the IMPACT project led by University Southern Denmark (SDU) and professor Thomas Andersen, Inucure is partner of the granted project IMPACT “”IMproving the Pig biomedical model for ACcelerating Translational research in anti-infection drugs and prophylaxes” supported by the Danish Open Discovery Innovation Network (ODIN) that is funded by the Novo Nordisk Foundation.

The IMPACT project (2025-2028) aims to improve the outcome of preclinical trials in pigs by establishing an assay platform for monitoring disease and immunogenicity status in the pig.

Based on input from expert scientists from industry and academia, the IMPACT team will identify relevant pig biomarkers of infection and inflammation that translates to humans. This knowledge will form the basis for establishing antibody-based immunoassays and immunogenicity assays. An integral part of the project is to improve infection protocols to better mimic human infection onset and pathogenesis. The team will also establish histopathology protocols for pig bladder and kidney tissue to enhance interpretation of tissue inflammation and invasive infection.